Elroy Catt

Secukinumab Cuts Chronic Pain in Hidradenitis Suppurativa

May 22, 2025

TOPLINE:Compared with placebo, secukinumab demonstrated superior pain reduction in moderate to severe hidradenitis suppurativa in two phase 3 trials. Improvements...

Elroy Catt

Secukinumab Cuts Chronic Pain in Hidradenitis Suppurativa

Study Links GLP-1 Drugs to Lower Cancer Risk

FDA Panel Recommends Monovalent COVID Vaccine for Next Season

FDA Chief Defends Job Cuts, COVID Booster Policy at Senate Hearing

Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

AI Assistance May Boost Accuracy of HER2-Low Scoring for Breast Cancers

Brave whistleblower uncovers pharma scam

FDA strengthens import controls on seafood, raspberries, mushrooms and other foods

Machine learning links up to 64 percent of Salmonella cases to chicken and vegetables

Marquis Who’s Who Honors Narendrasinh Gohil for Expertise in the Pharmaceutical Industry

What Works for Low Back Pain? New Study Suggests Not Much

Study Links GLP-1 Drugs to Lower Cancer Risk

FDA Panel Recommends Monovalent COVID Vaccine for Next Season

FDA Chief Defends Job Cuts, COVID Booster Policy at Senate Hearing

Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

AI Assistance May Boost Accuracy of HER2-Low Scoring for Breast Cancers

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories